AptarGroup

AptarGroup, Inc., also known as Aptar, is a United States-based global manufacturer of consumer dispensing packaging and drug delivery devices.[2][1] The group has manufacturing operations in 18 countries.[3]

AptarGroup, Inc.
Aptar
TypePublic
IndustryPackaging and drug delivery devices
Founded1992[1]
Headquarters
Crystal Lake, Illinois
,
U.S.
Key people
Stephan Tanda (CEO), Robert Kuhn (CFO), Shiela Vinczeller (CHRO)
ProductsSpray pumps and valves, metered-dose inhaler valves, nasal spray systems, dispensing closures, elastomer components for injection devices, active packaging
Revenue US$2.86 billion (2019)
Number of employees
14,000 (2019)

History

The company began as Werner Die & Stamping in Cary, Illinois, in 1946 and later incorporated as AptarGroup in 1992.[1][4] Aptar originally developed spray valves and pumps for consumer and household products. The company also later began producing nasal administration and pulmonary drug delivery devices such as nasal spray systems and metered-dose inhaler valves.[4][5][6][7] Biotech and pharmaceutical companies use Aptar's different Unidose and Bidose devices for the single or two-shot intranasal delivery of different medicines.[8]

In 2012, Aptar acquired Stelmi, a manufacturer of elastomer primary packaging components.[9]

In 2016, Aptar announced that it provided the delivery system for Adapt Pharma's Narcan.[10] Narcan is a naloxone hydrochloride nasal spray used as an emergency treatment for opioid overdoses.[10] Aptar's liquid spray drug delivery technology platform works as a ready-to-use, single-shot, unit-dose system for Narcan. It was the first FDA approved nasally administered, ready-to-use medication used to reverse the effects of an opioid overdose.[10] Narcan does not require any assembly, medical training, or needle injection.[11]

Later in 2016, Aptar acquired Mega Airless, a manufacturer of airless packaging solutions.[12] The company also entered into an agreement with Becton Dickinson & Company to develop new self-injection devices.[13][14]

Aptar entered into an agreement in 2016 with Propeller Health Partners to develop a digitally connected medication inhaler.[15] The company made an investment in Propeller Health Partners (now part of Resmed) in 2018.[16] The same year, Aptar acquired CSP Technologies, a material science company that manufactures active packaging solutions.[17]

In July 2019, the FDA approved Aptar Pharma's Unidose Powder System as the first intranasally-delivered, needle-free rescue treatment for severe hypoglycemia.[8]

In 2020, during the COVID-19 pandemic, Aptar invested in new tools to accelerate its molding equipment and assembly machines for pumps, but it still wasn't enough to keep up with demand.[18]

Sustainability

Aptar was named to Barron's list of 2019's Top 100 Most Sustainable U.S. Companies.[19]

References
  1. "AptarGroup Inc". Bloomberg. Retrieved 2019-08-12.
  2. "AptarGroup Inc". SEC. Retrieved 2019-08-12.
  3. "Aptar Joins the World Business Council for Sustainable Development". World Business Council for Sustainable Development (WBCSD). 2019-02-05. Retrieved 2019-08-12.
  4. "History of AptarGroup, Inc. – FundingUniverse". Funding Universe. Retrieved 2019-08-12.
  5. Mallory, Mike (2017-10-25). "Crystal Lake-based Aptar Pharma's opioid overdose reversal device goes nationwide". Northwest Herald.
  6. Strang, John; McDonald, Rebecca; Campbell, Gabrielle; Degenhardt, Louisa; Nielsen, Suzanne; Ritter, Alison; Dale, Ola (2019-09-01). "Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine". Drugs. 79 (13): 1395–1418. doi:10.1007/s40265-019-01154-5. ISSN 1179-1950. PMC 6728289. PMID 31352603.
  7. "Aptar Pharma Provides Unit-Dose Nasal Spray Technology for Opioid Overdose". Drug Development and Delivery. 2016-05-20. Retrieved 2019-11-18.
  8. "Aptar gets FDA approval for Unidose nasal drug delivery device". NS Medical Devices. 2019-07-26. Retrieved 2020-07-09.
  9. Taylor, Nick (2012-06-03). "Aptar to enter injectable device components with €165m buy". BioPharma Reporter. Retrieved 2019-08-12.
  10. "Adapt Pharma's Nasal Spray Uses Unit-Dose Delivery System". Healthcare Packaging. 2016-05-19. Retrieved 2020-07-09.
  11. "State health agency welcomes Narcan donations". AdVantage. 2018-02-08. Retrieved 2020-07-09.
  12. McDougall, Andrew (2016-02-02). "AptarGroup acquires Mega Airless for €200 million". Cosmetics Design. Retrieved 2019-08-12.
  13. Taylor, Phil (2016-09-13). "Aptar and BD join forces on auto-injector device". in-Pharma Technologist. Retrieved 2019-08-12.
  14. Rahman, Lu (2016-09-02). "Aptar Pharma teams up with BD to develop novel auto-injector". EPM Magazine. Retrieved 2019-08-12.
  15. Gormley, Brian (2016-02-25). "Propeller Health Joins With Aptar Pharma for Digitally Connected Medication Inhaler". Wall Street Journal. ISSN 0099-9660. Retrieved 2019-08-12.
  16. Moukheiber, Zina. "With $20 Million In Funding, Propeller Health Partners With Aptar Pharma To Make Digital Medicines". Forbes. Retrieved 2019-08-12.
  17. Johnson, Jim (2018-07-29). "AptarGroup buying CSP Technologies for $555 million". Plastics News. Retrieved 2019-08-12.
  18. Chaudhuri, Saabira (2020-07-10). "Soap Makers Are Cleaning Up Amid the Pandemic, but Can't Get Enough Hand Pumps". Wall Street Journal. ISSN 0099-9660. Retrieved 2020-07-17.
  19. Norton, Leslie P. (2019-02-08). "The 100 Most Sustainable U.S. Companies". Barrons. Retrieved 2019-08-12.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.